Shakeri, A.; Adanty, C. Romosozumab (sclerostin Monoclonal Antibody) for the Treatment of Osteoporosis in Postmenopausal Women: A Review. J Popl Ther Clin Pharmacol 2020, 27 (1), e25-e31. https://doi.org/10.15586/jptcp.v27i1.655.